Overall, the district court assesses that Brighter AB - in light of discussions and presentations in connection with the creditors' meeting - has not shown that there is a well-founded reason to assume that the viability of the business can be secured through the reconstruction. Furthermore, the district court assesses that an upcoming reconstruction plan does not have the prerequisites to be adopted and determined. The purpose of the company restructuring cannot therefore be assumed to have been achieved. The company restructuring must therefore cease and the matter be written off.

Further information will be published after the board's evaluation of the situation.

For more information, please contact:
Investor Relations
IR@brighter.se

Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB,  www.mangold.se  

About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.For more information, please visit our website at www.brighter.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 21 November at 11:20 CEST